Table 2 Progression of PNGAL and UNGAL in AKI, max KDIGO stage, need for RRT and mortality groups
| PNGAL values | ||||||
|---|---|---|---|---|---|---|
| Pre-op. (100) | Intra-op. (95) | 6 h (90) | 18 h (87) | 24 h (86) | 48 h (74) | |
| no AKI / mild AKI |
172 (102–331) |
196 (117–310) |
138 (93–282) |
170 (117–252) |
156 (113–243) |
116 (89–221) |
| severe AKI |
185 (114–287) |
232 (158–364) |
265 (177–429) |
326 (180–616) |
356 (215–666) |
369 (235–535) |
| P | 0.82 | 0.50 | 0.047 | 0.004 | < 0.0001 | < 0.0001 |
| no-RRT | 166 (79–270) |
192 (127–323) |
183 (86–281) |
168 (120–249) |
173 (122–286) | 134 (91–248) |
| need RRT | 204 (115–465) |
318 (204–407) |
341 (242–510) |
459 (306–749) |
608 (333–749) | 481 (292–689) |
| P | 0.27 | 0.015 | < 0.0001 | < 0.0001 | < 0.0001 | < 0.0001 |
| survivors |
197.49 (117–326) |
213.43 (129–337) |
199.73 (110–343) |
226.06 (129–335) |
228.09 (134–368) |
116.11 (117–326) |
| non-survivors |
165 (98–249) |
309 (105–389) |
279.5 (183–529) |
629.01 (256–759) |
619.10 (301–689) |
503.50 (281–697) |
| P | 0.51 | 0.64 | 0.22 | 0.001 | 0.001 | 0.001 |
| UNGAL values | ||||||
| Pre-op. (97) | Intra-op. (84) | 6 h (87) | 18 h (75) | 24 h (71) | 48 h (62) | |
| no AKI / mild AKI |
27 (17–244) |
35 (16–402) |
40 (18–143) |
62 (32–380) |
72 (26–248) |
147 (44–338) |
| severe AKI |
90 (23–254) |
119 (26–1669) |
424 (51–2802) |
312 (55–1542) |
329 (85–1290) |
247 (50–1820) |
| P | 0.90 | 0.008 | < 0.0001 | 0.006 | 0.004 | 0.23 |
| no-RRT | 27(16–167) | 26(15–98) | 70(27–160) | 78(35–262) | 110(28–318) | 70(18–317) |
| need RRT |
179 (34–513) |
602 (34–2912) | 1361(603–2131) |
855 (335–1979) |
660 (195–3109) |
667 (102–1650) |
| P | 0.001 | < 0.0001 | < 0.0001 | < 0.0001 | 0.001 | 0.002 |
| survivors |
33 (15–372) |
47.10 (20–522) |
113.10 (28–817) |
131.20 (37–818) |
147.80 (42–546) |
214.80 (95–1608) |
| non-survivors |
220.40 (49–549) |
181.71 (42–3046) |
1235.70 (77–3806) |
309.69 (138–3718) |
332.71 (109–3861) |
3291 (340–3950) |
| P | 0.02 | 0.11 | 0.005 | 0.06 | 0.09 | 0.0004 |
